These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 15566303

  • 21. A comparison of physicochemical property profiles of marketed oral drugs and orally bioavailable anti-cancer protein kinase inhibitors in clinical development.
    Gill AL, Verdonk M, Boyle RG, Taylor R.
    Curr Top Med Chem; 2007; 7(14):1408-22. PubMed ID: 17692029
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. In silico prediction of the solubility advantage for amorphous drugs - Are there property-based rules for drug discovery and early pharmaceutical development?
    Kuentz M, Imanidis G.
    Eur J Pharm Sci; 2013 Feb 14; 48(3):554-62. PubMed ID: 23262058
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Intramolecular hydrogen bonding in medicinal chemistry.
    Kuhn B, Mohr P, Stahl M.
    J Med Chem; 2010 Mar 25; 53(6):2601-11. PubMed ID: 20175530
    [Abstract] [Full Text] [Related]

  • 26. In silico model of drug permeability across sublingual mucosa.
    Goswami T, Kokate A, Jasti BR, Li X.
    Arch Oral Biol; 2013 May 25; 58(5):545-51. PubMed ID: 23123066
    [Abstract] [Full Text] [Related]

  • 27. Dependence of molecular properties on proteomic family for marketed oral drugs.
    Vieth M, Sutherland JJ.
    J Med Chem; 2006 Jun 15; 49(12):3451-3. PubMed ID: 16759087
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The graphical representation of ADME-related molecule properties for medicinal chemists.
    Ritchie TJ, Ertl P, Lewis R.
    Drug Discov Today; 2011 Jan 15; 16(1-2):65-72. PubMed ID: 21074634
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Relationships between the release of soluble drugs from HPMC matrices and the physicochemical properties of drugs.
    Fu XC, Liang WQ, Ma WX.
    Pharmazie; 2003 Mar 15; 58(3):221-2. PubMed ID: 12685821
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prediction of drug solubility from molecular structure using a drug-like training set.
    Huuskonen J, Livingstone DJ, Manallack DT.
    SAR QSAR Environ Res; 2008 Mar 15; 19(3-4):191-212. PubMed ID: 18484495
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The role of ligand efficiency metrics in drug discovery.
    Hopkins AL, Keserü GM, Leeson PD, Rees DC, Reynolds CH.
    Nat Rev Drug Discov; 2014 Feb 15; 13(2):105-21. PubMed ID: 24481311
    [Abstract] [Full Text] [Related]

  • 38. The hydrophobic effect. 2. Relative importance of the hydrophobic effect on the solubility of hydrophobes and pharmaceuticals in H-bonded solvents.
    Ruelle P, Kesselring UW.
    J Pharm Sci; 1998 Aug 15; 87(8):998-1014. PubMed ID: 9687345
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.